April 13, 2021
Abdominal aortic aneurysm (AAA) patients who are 90 or older fare just as well as their younger counterparts after endovascular aneurysm repair (EVAR), a study shows.
After accounting for differences in comorbidity burden and other factors with propensity-score matching, 30-day mortality and major adverse event rates did not significantly differ between nonagenarians and patients from other age groups, lead author Carlota Fernandez Prendes, MD (Ludwig-Maximilians-University Hospital, Munich, Germany), and colleagues report.
The findings, published in the April 20, 2021, issue of the
Journal of the American College of Cardiology, were consistent in patients with either intact or ruptured aneurysms.
“Just using age as a [criterion] for intact and for ruptured aneurysms should not exclude patients from receiving treatment” with EVAR, Prendes told TCTMD. Instead, she and her co-authors recommend “tailored indications and carefully balanced risk assessment” to